LEAVE NO THING BEHIND

Minimally Invasive Micro Sclerostomy (MIMS®) is a Stentless, Simple & Fast Glaucoma treatment which effectively lowers the IOP without the need for invasive surgery.

A Minimal invasive & Stent-less Treatment Glaucoma Innovation

MIMS® is a rapid & minimal invasive procedure at the forefront of Interventional Glaucoma treatments. Fewer post-op complications allows for effective IOP management.

How MIMS® Works

Minimally Invasive Micro Sclerostomy is fast, accessible & effective. It works by inserting a specially designed cutting tool into the sclera & removing a small channel of tissue. This channel will remain open & contentiously drain, effectively reducing IOP.

A Ready-to-Use Surgical System

MIMS® is a lightweight surgical system intended for use by trained professional ophthalmologists. It’s easy to use & learn, intuitive to operate & requires fewer staff to assist in non-surgical environments. A central control touchscreen demonstrates the surgical parameters & a foot pedal initiates the precise handheld cutting tool movement.

Precision Glaucoma Treatment Technology

Novel Glaucoma treatment practiced globally. Learn more about Sanoculis and MIMS® surgical device innovation.

Outstanding Clinical Performance

2:03±0:43

Min Procedure
duration

43%

IOP Reduction after 12
Months

85%

Medication reduction
at 12 mo.

ZERO

Major intra/post-op
complications

MIMS® Testimonials

News & Publications

Global Distribution & Partners

Germany

MEyeTech Gmbh

Werner-Heisenberg-Str. 5, Alsdorf 52477

49 (0) 2404 552910

info@meyetech.de

https://www.meyetech.de/

Germany

Italy

Israel

Switzerland

Holland & Belgium

France

Spain

Norway & Iceland

UK & Ireland

This site uses cookies to improve visitor experience & analyze web traffic. We may share usage data with analytics partners to enhance & optimize. By clicking accept, you consent to store on your device technologies described in our privacy policy & terms of use. Thank you. privacy policy & terms of use